Youtube growth is harder in 2026. This guide breaks down why people buy views for personal channels, what to look for in a ...

A new investigation reveals YouTube's algorithm floods kids' feeds with bizarre AI videos after trusted channels, while creators profit from the synthetic content with millions of views.

Until very recently, that was the message on the Trump administration’s just-launched website for its new protein-centric dietary guidelines, RealFood.gov, which was announced in a Super Bowl ...

A prolific initial access broker tracked as TA584 has been observed using the Tsundere Bot alongside XWorm remote access trojan to gain network access that could lead to ransomware attacks. Proofpoint ...

You can unlock many YouTube Premium-like features for free on desktop using browser extensions. Tools like Enhancer for YouTube, uBlock Origin Lite, Unhook, Volume ...

YouTube is continuing to lean into AI to help make content, and that next YouTube Short you watch might not contain real footage of its creator. CEO Neal Mohan announced the latest move in this trend ...

YouTube Shorts viewers might soon see AI versions of their favorite creators when scrolling through their feeds. YouTube CEO Neal Mohan announced on Wednesday that ...

AI will be a “boon to creatives who are ready to lean in,” according to YouTube chief Neal Mohan. But at the same time, the video giant is taking steps to minimize the spread of low-quality AI content ...

You’ll soon be able to watch whatever you want side by side. You’ll soon be able to watch whatever you want side by side. is a news writer who covers the streaming wars, consumer tech, crypto, social ...

Cross Bot will analyze your games in Crossplay, a new two-player word game from The Times. By Asmaa Elkeurti Tom Giratikanon and Eve Washington New York Times Games has launched Crossplay, a new ...

Dekan Apajee does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...

Botensilimab and balstilimab combination therapy is approved in France for ovarian cancers and soft tissue sarcomas under the AAC framework. The therapy, initially for microsatellite-stable metastatic ...